Programme at a Glance

Tuesday,
20 June 2023

9:00 – 11:00

Opening Ceremony

Sin-Hyeog Im
POSTECH & ImmunoBiome Inc., South Korea

Evolution of Probiotic Science
20 Years in the Making – End of the Beginning?

George Paraskevakos
International Probiotic Association, Canada

Probiotic Business Framework Overview

Elinor McCartney
Argenta, Spain  

EU, EFSA and Innovation in the Food Chain – 2000 to 2050. What’s Next?

11:00 – 11:30

Coffee Break

Live Biotherapeutic Products

Philippe Langella  
INRA, France

Our Intestinal Microbiota as a Source of Live Biotherapeutics for Animal and Human Health

Jonna Koper
Lesaffre International, Lesaffre IST, France

Impact of Faecalibacterium Sp. on Modulation of The Human Gut Microbiota Using The In Vitro Simulator of The Human Microbial Ecosystem (SHIME)

Marco Van Es  
Bac2nature foundation, the Netherlands

An Understanding of the One Health – Holomicrobiome Evidence Elevates the Microbiome Field. Human Microbiomes Show Our Inseparable Connection With “Nature”

13:00 – 14:00

Lunch Break

ILSI Europe session: Emerging concepts of host-microbe interactions and its molecular implications for probiotic administration. The ecology and physiology of the small intestine versus the colon: potential consequences for probiotic administration

Daisy Jonkers  
Maastricht University, the Netherlands

Introduction on Host-Microbiome Interactions in the Small Versus Large Intestine

Benjamin A. H. Jensen
University of Copenhagen, Denmark

Diet Dependency in Probiotic Efficacy

Christian Sina
University of Lübeck, Germany

Therapeutic Potential of the Intestinal Microbiota in functional GI Diseases

Hands-on Workshop

Introduction Into Basic Experimental Procedures With EpiIntestinal

A Reconstructed 3D Model Of Human Intestinal Epitheliuma

Limited to 30 participants only

16:00 – 16:30

Coffee Break

Market, where to Next?

Ewa Hudson
Lumina Intelligence, United Kingdom

The European E-commerce Market of Probiotics, Prebiotics and Postbiotics – Companies, Products, Benefits, Reviews

Nina Vinot
TargEDys, France

The Importance of the Mechanism of Action in Probiotics Development

Elisabetta Caselli
University of Ferrara, Italy

Probiotic Sanitation as a Sustainable Tool for IPC and AMR Control

Gustav Lindved
Clinical Microbiomics, Denmark

Microbiota Engraftment and Deep Strain Characterization: Novel Tools for Probiotic Design and Development to Reduce Cost, Risk and Time-to-Market

Bodo Speckmann
Evonik Operations GmbH, Germany

Enhancing Gluten Degradation in Humans through a Novel Probiotic Consortium of Lactobacillus and Bacillus Strains

Karl Alex Hedin
Technical Universtiy of Denmark, Denmark

Unlocking the Potential of Probiotics: Genetically Engineering Saccharomyces boulardii for Effective Obesity Management

Science & Industry Connections

Tell us in 3 minutes what are you doing and which partner, capacity, competence are you looking for or offering

Immunology Workshop
Lecturer:
Sin-Hyeog Im: POSTECH & ImmunoBiome Inc.,
South Korea

Probiotic Components in Modulating the Host Immune Response

  • How to identify and characterize the immunological properties of specific probiotic strains?
  • What are the effector molecules and their mode of action?
  • What are the key components of probiotics in communicating with the host’s immune system?

18:40

Networking Bar

Meet those who are seeking for partners or speakers from the programme and have a drink and chat together

Wednesday, 21 June 2023

09:00 – 10:35

Functional Foods, Infant Nutrition, HMO’s

Gwenael Jan
STLO- INRAE- Institut Agro, Microbiology, France

Beneficial Propionibacteria: from Traditional Cheeses to Next Generation Probiotics

Bernd Stahl
Danone Nutricia Research, the Netherlands

HMOS: Great Food for the Little Ones

Jiri Hrdy
Faculty of Medicine – Charles University, Czech Republic

Early Postnatal Supplementation of Newborns by Probiotic Strain E. coli O83:K24:H31 and Its Effect on Allergy Incidence, Selected Immune Charateristics and Microbiota

Adrienne Weiss
Yili Innovation Center Europe, the Netherlands

Lacticaseibacillus Paracasei subsp. Paracasei Strain K56 Reduces Metabolic Effects In Obese Individuals

Simon Aloo
Kangwon National University, South Korea

Protective Effect of Fermented Hempseed Extracts Against Obesity and Obesity-induced Oxidative Stress and Neurodegenerative Disorders

Ashwinipriyadarshini Megur
Vilnius University, Lithuania

In Vitro Screening and Characterization of Lactic Acid Bacteria from Lithuanian Fermented Food with Potential Probiotic Properties

Bacteriocins and Antimicrobial Peptides Symposium BAMP2023

Svetoslav Todorov
Sao Paulo University, ProBacLab, Brazil

Multitasking as Primary Objective in the Selection of Beneficial Microorganisms, Complex Screening Approach

Paul Cotter
Teagasc Food Research Centre, Ireland

Targeting Specific Components of Microbiomes through Natural and Engineered Antimicrobial Peptides

Valentína Focková
Centre of Biosciences of the Slovak Academy of Science, Slovakia

Experimental Application of Mundticin-Like Substance EM 41/3 in Horses of the Breed Norik

10:35 – 11:05

Coffee Break

Ton Baars
Utrecht University, Immunopharmacology, Germany

Immunological Impact and Bio-Active Peptides of Kefir Made from Starter Culture or Back-Slopped Grains Depend on Heat Treatment of the Cow Milk Used

Humberto Martinez Montoya
Universidad Autónoma de Tamaulipas, Mexico

Genomic Features of Lactiplantibacillus sp. and Lacticaseibacillus sp., Two Novel Bacterial Strains with Probiotic Potential Isolated from the Mexican Fermented Beverage “Pozol”

Personalised Medicine, Diagnostics, Standardisation

Paul Cotter
Teagasc Food Research Center, Ireland

Fermented Foods and Potential Contributions to Personalised Nutrition

Remco Kort
Vrije Universiteit Amsterdam, the Netherlands

Understanding Probiotic Properties of the Human Vaginal Bacterium Lactobacillus crispatus

Yosep Ji
HEM Pharma, South Korea

Understanding Microbiome for Personalized Approach

Dennis Zeilstra
Microbiome Center, the Netherlands

Integration of Evidence-Based Medicine and Personalized Medicine in Personalized Microbiome Treatments

Koen Venema
Beneficial Microbes Consultancy, the Netherlands

Personalized Nutrition Advice to Optimize Gut Microbiota Composition – Results of the Friends & Family Study

Coffee Break

Andrea Laukova
Institute of Animal Physiology, Slovakia

Enterocins and Their Application Potential in Animal Breeding

Sune K. Jensen
University of Copenhagen, Denmark

Oral hBD2 Administration Requires a Functional Gut Microbiota to Mitigate Cigarette Smoke-Induced Lung Inflammation

Monika Pogány Simonova
Institute of Animal Physiology, Slovakia 

Bacteriocins – a New Approach to Increase Products Quality of Food-producing Animals

Santosh Tiwari
Maharshi Dayanand University, India

Halocins of Haloarchaea: Antimicrobial Peptides with Extreme Stability under Diverse Conditions

12:50 – 13:50

Lunch Break

Lunch Break

Postbiotics

Arthur C. Ouwehand
International Flavors & Fragrances, Finland

Where Do Probiotics Go When They Die? A Short Introduction to Postbiotics

Wilbert Sybesma
Microbiome Solutions, Switzerland

Postbiotics – Mechanisms of Actions and Where this Field Is Going to

Simone Guglielmetti
Università degli Studi di Milano, Italy

Bridging Research and Industry on Health-Promoting Agents from Non-Viable Microbes: Toward a Shared Consensus on Terminology and Definitions

Eva Armengol
Scientific Manager at AB-BIOTICS, Spain

Applicability of Postbiotics: A New World to Discover

Animal Health Symposium

Gert Folkerts
Utrecht Institute for Pharmaceutical Sciences, the Netherlands

Galacto-Oligosaccharides Alleviate Lung Inflammation by Inhibiting NLRP3 Inflammasome Activation in Vivo and in Vitro

Ivan Rychlik
Veterinary Research Institute, Brno, Czech Republic

Chicken and Environmental Microbiota

Viviana Molnar-Nagy
Dr. Bata Ltd, R&D, Ócsa, Hungary

Highly Effective Probiotic-based Feed Additive Against Digestive Disorders in Conventional Broiler Rearing

15:45 – 16:15

Coffee Break

Coffee Break

Postbiotics – Panel Discussion
Moderator: Arthur Ouwehand

Panelists: Wilbert Sybesma
Simone Guglielmetti
Eva Armengol
Philippe Langella
George Paraskevakos

20:00…

Conference Dinner on the Boat Restaurant
Informal Discussions Continues

Thursday, 22 June 2023

09:00 – 10:30

Better Science – Better Studies
Clinical Trials – Selection Criteria,
New Approach to Clinical Studies

Hania Szajewska
Medical University of Warsaw, Poland

Clinical Studies – How to Read and Evaluate?

Robert JM Brummer
Örebro University and University Hospital, Sweden

Pro- and Prebiotics for Improved Mental Health – How Does it Work and How Do We Measure It?

Prebiotics

Maria Wiese 
TNO, the Netherlands

Structure and Function of Non-digestible Carbohydrates in the Gut Microbiome

Yala Stevens
BioActor BV, Research & Development, Maastricht, Netherlands

α-Gluco-Oligosaccharides: Clinical & Mechanistic Research

10:35 – 11:05

Coffee Break

Yunus Emre Tunçil
Necmettin Erbakan University, Turkey

Bio-Catalytical Syntheses of Non-Digestible α-Glucans with Different Structural Features and Their Impacts on Colonic Microbiota and Metabolic Outputs

Enes Dertli
Yildiz Technical University, Turkey

A Glucansucrase Based Engineering to Produce Novel Poly-Oligosaccharides with Prebiotic Functions

Marina Elli
Coree Srl, R&D, Milan, Italy

Fermentation of Oat Beverage by Probiotic Blends and Assessment of Their Impact on the Absorption Profiles

Valentina Taverniti
SACCO SYSTEM, Italy

Gut microbiota modulation by probiotics improves inflammaging

Yuri Lee
Handong Global University, South Korea

The Beneficial Effect of Bifidobacterium animalis subsp. lactis HEM20-01 in a Chronic Unpredictable Mild Stress and LPS (CUMSLPS)-induced Depressive-like Mouse Model by Modulating the Gut Microbiota and the Gut Metabolites

Erwin Geroleo
Jose R. Reyes Mem. Medical Center, Philippines

The Effectiveness of Probiotics in the Treatment of Minimal Hepatic Encephalopathy (MHE) among Patients with Cirrhosis: An Expanded Meta-Analysis

Wenrui Li
Nanyang Technological University, Singapore

Ex Vivo Evaluation of the Polysaccharide-Encapsulated, Host-Derived Microbial Compositions on the Gut Microbiota of Jade Perch (Scortum barcoo)

Meryem Boujnane
Université de Rouen Normandie, France

Inter-Kingdom Signaling of Stress Hormones: Sensing and Modulation of Pathogens/Probiotics/Host Interactions?

12:45 – 13:45

Lunch Break

Gut-Health axis (brain, skin, lung, liver, joint)

Anna Chwalibóg
Integral Solutions, Poland

Precision Microbiome-Based Therapeutics Using CRISPR Genome Engineering

Amine Zorgani
S-Biomedic, JLABS, Belgium

Topical Probiotics in Skin Barrier Function – Report on a Double-Blinded Placebo Controlled Pilot Study in Stressed Skin with Live Cutibacterium acnes

Laura Huuskonen
IFF Health & Biosciences, Finland

Effects of Bifidobacterium animalis subsp. lactis Bl-04 on Skin Wrinkles and Dryness: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial

Petr Ryšávka
Probiotics&Microbiome Innovations, Czech Republic

Development of a Topical Cosmetic Product Containing Live Probiotic Cultures

Hiroshi Ohno
RIKEN Center for Integrative Medical Sciences, Japan

Smoking Modulates Gut Ecosystem of Patients with Inflammatory Bowel Diseases to Attenuate Ulcerative Colitis while Exacerbate Crohn’s Disease

Thomas Berngruber
Evonik Operations, Creavis – Life Science, Germany

Specialized Pro-Resolving Lipid Mediators (SPMs) from Synbiotic Application of Bacillus megaterium DSM 32963 and Polyunsaturated Fatty Acid (PUFA) Lysin-Salts Counteract Inflammation in Ex-Vivo Colon Biopsies of IBD Patients

15:30 – 16:00

Coffee Break

Young Scientists Award
Best Poster Award
End of the Conference

Viktor Bielik
Comenius University Bratislava, Slovakia

The Combination of Probiotics and Physical Training on Gut Microbiota and Metabolomics

Mariya Peneva
Medical Center “Eurozdrave-Bulgaria”, Bulgaria

Application of Probiotic Formula, Containing Lactobacillus Bulgaricus DWT1 in Patients with COVID-19

Technology, Production(costs), Good practices, Efficacy, Rehydration

Elisa Salvetti
University of Verona, Italy

What is New in Taxonomy

Jiri Snaidr
Vermicon AG, Microbiology, Germany

The Power of Fluorescence In Situ Hybridisation – How FISH Changes Enumeration and Quality Control of Probiotics and Enables Spatial Microbiome Analysis

Ioannis Vrasidas
the TIM Company, the Netherlands

TIM in Vitro Dynamic Gastrointestinal Model and Applications Thereof in Pre- and Probiotic Related Studies

Ilia Belotserkovsky
BIOASTER, Microbiota Program, France

Ex-Vivo Experimental Approaches to Explore the Immunomodulatory and Homeostatic Potential of Prebiotics and Probiotics

18:00

Farewell Drink